Memorial Hospital Research Laboratories

The James Young Lab



Memorial Sloan Kettering Hematologic Oncologist James W. Young
James W. Young, MD


Our lab studies human dendritic cells, which are critical to the onset of cellular immunity. Dendritic cells also provide an important link between innate and adaptive immune responses. Our work is broadly informed by issues in clinical transplantation and tumor immunology.

View Lab Overview

Young lab



Memorial Sloan Kettering Hematologic Oncologist James W. Young

James W. Young, MD


  • Physician-scientist James Young studies innate and adaptive immunity against tumors and viruses stimulated by human dendritic cells.
  • MD, Vanderbilt University
Email Address
Office Phone
View physician profile
Physician profile


James Young, MD
James Young

Lab Head

David Chung


Shane Curran

Research Scholar

Katherine Pronschinske

Research Technician

Mitsu Fink

Senior Research Technician

Erin St. Angelo

Research Technician

Justin Shyer

Research Technician

Lab Affiliations

Get in Touch


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

James W. Young discloses the following relationships and financial interests:

  • Amgen
    Ownership / Equity Interests
  • Merck & Co Inc.
    Ownership / Equity Interests
  • Pfizer, Inc.
    Ownership / Equity Interests

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at

View all disclosures